
A deeptech start-up founded by a group of Bristol and London-based academics is to take part in a major global study exploring how quantum computing can be used to develop a treatment for the progressive muscle-wasting disease myotonic dystrophy. Phasecraft, which was launched in 2019 as a spin-out from...